MIT’s A11 Drug: Reducing Inflammation and Enhancing Memory in Alzheimer’s Disease
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical…